Advertisement
Home Blog Page 3594
Hormone replacement therapy for women may not be as potentially risky as previously thought

ENDO: HRT May Not Be As Risky As Once Thought

0
But other experts warn it's too soon to say the treatment is safe
Cresemba (isavuconazonium sulfate) has been approved by the U.S. Food and Drug Administration to treat invasive aspergillosis and invasive mucormycosis

FDA Approves Cresemba for Serious Fungal Infections

0
New drug targets cell walls of the fungi; available in oral and intravenous formulations

Society of Interventional Radiology, Feb. 28-March 5

0
The Society of Interventional Radiology's Annual Meeting The annual meeting of the Society of Interventional Radiology was held from Feb. 28 to March...
For patients undergoing coronary artery bypass graft surgery

Anesthesiologists Impact CABG Surgery Outcomes

0
Rate of death, major complications varies significantly across anesthesiologists
Structural joint damage measured with magnetic resonance imaging can predict knee replacement in the following year

Abnormalities on MRI Predict Knee Replacement

0
Measures of structural joint damage relate to clinical prognosis in the following year
Practices' adherence to a quality-assurance program for point-of-care testing devices can be improved with reminders

Reminders Improve Practices’ Quality-Assurance Testing

0
Postal, computer reminders equally increase adherence to quality-assurance program
A monthly educational intervention paired with a web-based quality improvement tool is feasible for increasing the proportion of inappropriate proton pump inhibitor prescriptions discontinued at hospital discharge

Educational Intervention Can Cut Inappropriate PPI Prescriptions

0
Increase in proportion of PPIs discontinued at hospital discharge after intervention implementation
The U.S. Food and Drug Administration has approved Zarxio (filgrastim-sndz)

FDA Approves First Biosimilar Drug in U.S.

0
Zarxio is highly similar to long-sanctioned cancer drug
The U.S. Food and Drug Administration has approved the first device to treat dialysis-related amyloidosis (DRA)

FDA: Device Authorized for Use in Dialysis-Related Amyloidosis

0
Lixelle Beta 2-microglobulin Apheresis Column authorized for use in DRA
A model has been proposed to explain the influence of inadequate vitamin D and omega-3 fatty acids on brain dysfunction via serotonin levels

Model Explores Impact of Vitamin D, Omega-3 Deficiency

0
Model explains influence of inadequate levels of vitamin D, omega-3 fatty acids on brain dysfunction